FDAsafety guidance66% confidence
Science & Research
Source: FDA
Why This Matters
Why this matters: provides agency context on safety guidance that may shape timing or evidence expectations for Accord Biopharma; the same agency is already in play for this signal, so precedent weight is higher.
Regulatory Analysis
In collaboration with industry and the public, FDA creates an annual list of regulatory science initiatives on generic drugs.
Supporting Context
- Therapeutic area
- Hematology · Neutropenia
- Sub-indication
- General
Related signal: FDA Accepts BLA761147 for PEGFILGRASTIM-PCCG by Accord Biopharma